Any condition, whether it be cancer, heart disease, or arthritis, can be treated with awareness. It is common knowledge that arthritis can hurt, swell, and inflame one or more joints. Instead of referring to a single illness, it is an all-encompassing term used to describe a number of disorders. It's one of the most prevalent health problems in the nation.
There are more than 100 different types of arthritis, but the most common are rheumatoid arthritis and osteoarthritis (OA) (RA). OA is the deterioration of the cartilage that covers the ends of bones, as opposed to RA, which largely affects the immune system and can harm joints, muscles, connective tissue, tendons, and fibrous tissue. Any joint, including the hands, hips, knees, and spine, can be harmed by it.
There are more than 180 million cases of arthritis in India, making it more prevalent than many other well-known diseases including diabetes, AIDS, and cancer, according to an analysis of arthritis tests conducted in SRL Diagnostics' facilities. About 14% of Indians seek medical attention each year for this joint issue. Despite the fact that this condition is quite common, there are still a number of beliefs that prevent people from receiving the treatment they need to relieve their symptoms and enhance their quality of life. Dr. Biren Nadkarni, Senior Orthopedic Consultant and Joint Replacement Surgeon from Sitaram Bhartia Institute and Holy Family Hospital in New Delhi, dispels some common myths regarding arthritis in India. Let's look at it:
Arthritis is An Old-Age Disease and Cannot Affect Children
Fact: Although there are numerous varieties of arthritis that can afflict both children and young adults, the condition is more prevalent in older people. The most frequent kind of arthritis in children, juvenile arthritis (also known as childhood arthritis or juvenile rheumatoid arthritis), can permanently harm joints.
All Joint Pains Are Arthritis
Fact: A number of illnesses, including tendonitis, bursitis, and other soft-tissue injuries, can cause joint pain and have a pain profile resembling that of arthritis. Therefore, it is crucial to obtain a precise medical diagnosis before treating any kind of joint discomfort.
When You Start Experiencing Joint Pain, You Should Wait to See If It Goes Away on Its Own
Fact: Absolutely false. Early detection and treatment of arthritis can not only save your joints but also protect your important organs from harm. Some types, like rheumatoid arthritis, can harm the heart, blood vessels, brain, skin, eyes, lungs, and skin. It is important to identify the type of arthritis you have as soon as possible since many treatments are available, and starting the right course of treatment can help you avoid suffering long-term effects.
Exercising Will Worsen Your Condition
Fact: Exercise helps lessen discomfort and swelling while boosting strength, range of motion, and flexibility. Inactivity can make the symptoms worse, causing the pain and swelling to worsen. Before you enrol yourself in any exercise program, it is also important to know what your limits are and what level of exercise you can benefit from.
Heating Pads Relieves Sore Joints
Fact: Joint pain can be relieved by ice as well as heat. Heat can ease pain and stiffness in joints and muscles when applied properly. The cold application might help to reduce soreness and joint inflammation.
When a joint is stiff or hurting, people should apply heat before exercising. Additionally, cold can reduce pain and may be helpful if a joint is irritated, especially if there is swelling post - exercise.
Hand And Feet Will Remain Deformed
Fact: Deformities may result from untreated and undiagnosed arthritis. However, this can be avoided with early detection and treatment. Most patients with arthritis lead functional and productive lives.
Dr. Biren Nadkarni concludes by saying, "despite advancements in medicine, there is still much to learn about arthritis. Simple precautions should be taken in order to stop the disease process from developing and affecting our life. Arthritis is accompanied by a number of controllable and non-modifiable risk factors. We should be aware that by maintaining a lifestyle that includes exercise and a nutritious, balanced diet, we may lower the risk of some types of arthritis and halt their progression, in keeping with this year's theme, it's in your hands, take action. Better treatments will undoubtedly develop as scientists continue to study these disorders". (Dr. Biren Nadkarni, Senior Orthopedic Consultant)
Read More► Liver Cancer Cases, Deaths Estimated to Rise by Over 55% by 2040
London: Increased air pollution has been linked with rise in risk of autoimmune diseases, according to a twin study.
Two abstracts presented by Dr Giovanni Adami at the 2022 EULAR Congress looked at the issue of environmental exposures and their role in disease development.
Particulate matter (PM) is defined as everything in the air that is not a gas, and includes a variety of chemicals and materials, some of which can be toxic.
Data from over 80,000 people in a retrospective observational study in Italy found a positive association between PM levels measured at local air-quality stations and the risk of autoimmune diseases.
In fact, every 10 micrograms per cubic metre increase in PM10 concentration was associated with an incremental 7 per cent risk of having autoimmune disease.
Exposure to PM10 above 30 micrograms per cubic metre and PM2.5 above 20 micrograms per cubic metre was associated with 12 per cent and 13 per cent higher risks of autoimmune disease, respectively.
When broken down by individual diseases, exposure to PM10 was associated with an increased risk of rheumatoid arthritis (RA) but no other autoimmune diseases, whereas exposure to high levels of PM2.5 was associated with an increased risk of RA and inflammatory bowel disease.
Overall, chronic exposure to particulate air pollution above the threshold for human protection was associated with a 10 per cent higher risk of developing immune-mediated diseases.
In a separate study, the same team looked at the association between long-term exposure to PM and osteoporosis in almost 60,000 women at high risk of fracture.
The results showed that exposure to PM2.5 was negatively associated with low bone mass at the top of the thigh bone and lumbar spine.
Chronic exposure above 25 micrograms per cubic metre for PM2.5 and 30 micrograms per cubic metre for PM10 was associated with a 16 per cent and 15 per cent higher risk of having osteoporotic bone mass scores at any site.
The researchers concluded that long-term exposure to air pollution was associated with higher risk of osteoporosis.
Further, among the RA patients, high silica exposure was independently associated with lung abnormalities such as interstitial lung disease and mediastinal lymphadenopathy. (Agency)
Read More► Why 5 Minutes of Sun Makes Your Mood Better
Rumalaya Liniment is an effective ayurvedic medicine that helps to relieve pain, inflammation, and stiffness in joints and muscles due to arthritis and traumatic inflammatory conditions. Rumalaya Liniment includes Gandhpurataila and Karpoora. Indian oil of wintergreen (Gandhapura taila) contains 98% of the well-known painkiller methyl salicylate.
When applied topically, it relieves pain associated with rheumatism, neuralgia, and sciatica. Camphor (camphor) is a mild analgesic and is an analgesic. By expanding capillaries and increasing blood flow, camphor effectively treats deep-seated pain associated with joints and bones.
It is manufactured by the renowned ayurvedic company The Himalaya Drug Company. Rumalaya Liniment is a typical Ayurvedic medicine enriched with the goodness of Ayurvedic herbs and ingredients. The main ingredients of the Rumalaya Liniment are the gandhpura and camphor.
It is 100% Ayurvedic and safe and available in cream, oil, tablet, and liniment form in the market. Rumalaya liniment dosage depends on the age, gender, weight, and condition of the patient. So let's start this article in which you will get complete information about Rumalaya liniment.
Rumalaya Liniment Ingredients
Each 1ml Contains:
Oil Extracts of:
Rumalaya Liniment Uses
sprains and strains
Arthritis-related conditions such as osteoarthritis, gout, frozen shoulder, etc.
Cervical and lumbar spondylitis
Lower back pain
Painful/traumatic inflammatory conditions such as fibrositis, bursitis, synovitis, capsulitis, tenosynovitis, myositis and sciatica
Rumalaya Liniment Benefits
Provides relief for indications such as pain, inflammation, and stiffness of muscles and joints.
Beneficial for people with arthritis and traumatic inflammatory conditions.
It contains camphor, which increases blood flow and treats the deepest pains in the joints and bones.
Indian oil of wintergreen effectively relieves pain caused by diseases such as rheumatism, neuralgia, sciatica, etc.
Rumalaya Liniment Side Effects
Rumalaya liniment is not known to have any side effects when applied according to the prescribed dose and frequency.
Rumalaya Liniment Buy Online
Rumalaya Liniment Dosage
Clean the affected area. Pour in four to five drops of Rumalaya liniment and massage gently until the liniment is absorbed. Apply two to three times a day or as directed by the Ayurvedic doctor.
Rumalaya Liniment Shelf Life
Rumalaya Liniment shelf life is best 2 years from the manufacturing date.
Rumalaya Liniment Storage & Safety Information
Rumalaya Liniment storage and safety information are:
Read the label carefully before use
Protect from direct sunlight
Use under medical supervision
Store in a cool and dry place
Rumalaya Liniment Frequently Asked Questions
Q. What is Rumalaya Liniment?
Ans. Rumalaya Liniment is an effective Ayurvedic medicine that helps to relieve pain, inflammation, and stiffness in joints and muscles due to arthritis and traumatic inflammatory conditions.
Q. How much shelf life has Rumalaya Liniment had?
Ans. Rumalaya Liniment shelf life is best 2 years from the manufacturing date.
Q. How to use Rumalaya Liniment?
Ans. Clean the affected area. Pour in four to five drops of Rumalaya liniment and massage gently until the liniment is absorbed. Apply two to three times a day or as directed by the Ayurvedic doctor.
Q. Is Rumalaya Liniment safe?
Ans. Yes, Rumalaya Liniment helps to treat pain, inflammation, and stiffness in joints and muscles. It helps to relieve pain, inflammation, and stiffness in joints and muscles due to arthritis and traumatic inflammatory conditions.
Q. Does Rumalaya Liniment have any chemical ingredients?
Ans. Rumalaya Liniment is also made from natural herbs like gandhpura taila and karpoora and no kind of artificial ingredient has been used in its making.
Q. What is Rumalaya Liniment used for?
Ans. Rumalaya Liniment helps to treat pain, inflammation, and stiffness in joints and muscles. It helps to relieve pain, inflammation, and stiffness in joints and muscles due to arthritis and traumatic inflammatory conditions.
Q. Does the Rumalaya Liniment work?
Ans. Rumalaya Liniment may play a beneficial role that helps to treat pain, inflammation, and stiffness in joints and muscles. It helps to relieve pain, inflammation, and stiffness in joints and muscles due to arthritis and traumatic inflammatory conditions.
Q. Is Rumalaya Liniment effective?
Ans. Yes, Rumalaya Liniment is an effective formula.
Q. Does Rumalaya Liniment have any side effects?
Ans. Rumalaya liniment is not known to have any side effects when applied according to the prescribed dose and frequency.
Rumalaya Liniment Reference
आयुष मंत्रालय रुमेटॉयड अर्थराइटिस के उपचार में आयुर्वेद की प्रभावशीलता की जांच करने के लिए विश्व के प्रथम मल्टीसेंटर फेज-III नैदानिक परीक्षण का संचालन कर रहा है।
नैदानिक परीक्षण मानव उपयोग के लिए फार्मास्यूटिकल के लिए तकनीकी आवश्यकताओं के सामंजस्य के लिए अंतरराष्ट्रीय परिषद के सख्त नियमों - उत्कृष्ट परीक्षण प्रक्रिया (आईसीएच-जीसीपी) के अनुरूप किया जाएगा और इसकी निगरानी अमेरिका के लॉस एंजिल्स स्थित कैलिफोर्निया विश्वविद्यालय के विख्यात रुमेटॉलॉजिस्ट डॉ. डैनिएल इरिक फुस्र्ट द्वारा की जा रही है।
यह परियोजना रुमेटॉयड अर्थराइटिस के प्रबंधन में आयुर्वेद की प्रभावशीलता पर पहले मल्टी सेंटर फेज-III डबल ब्लाइंड डबल डमी नैदानिक परीक्षण में से एक है। इसका संचालन आर्या वैद्य फार्मेंसी (कोयंबटूर) लिमिटेड के साथ संबद्ध एक अनुसंधान संस्थान एवीपी रिसर्च फाउंडेशन तथा आयुष मंत्रालय के तहत भारत सरकार की एक एजेंसी सेंट्रल काउंसिल फॉर रिसर्च इन आयुर्वेद (सीसीआएएस) द्वारा किया जाएगा।
विश्व के विख्यात रुमेटॉलॉजिस्ट डॉ. एडजार्ड अर्नेस्ट, जो वर्तमान में अर्थराइटिस एसोसिएशन ऑफ साऊथ कैलिफोर्निया (एएएससी) में नैदानिक परीक्षण के निदेशक हैं तथा सीएएम के मुखर आलोचक हैं, ने पूरक और वैकल्पिक दवा (सीएएम) पर भविष्य के परीक्षण के लिए एक मॉडल के रूप में अध्ययन का समर्थन किया।
उन्होंने अध्ययन की रूपरेखा बनाई है और इसका मार्गदर्शन करेंगे। इस परीक्षण के संबंध में, डॉ. डैनिएल इरिक फुस्र्ट ने नैदानिक अनुसंधान के स्वर्णिम मानकों का अनुपालन करते हुए अध्ययन का संचालन करने पर केंद्रों के सभी जांचकर्ताओं को प्रशिक्षित करना तथा इस प्रकार आयुर्वेद के वैश्वीकरण को सक्षम बनाना आरंभ कर दिया है।
एवीपी रिसर्च फाउंडेशन के निदेशक तथा इस अध्ययन के सह-परीक्षणकर्ता डॉ. सोमित कुमार ने कहा, ‘‘ एएमआरए, एक डबल ब्लाइंड डबल डमी रैंडोमाइज्ड नैदानिक परीक्षण रुमेटॉलॉजी में आयुर्वेद अनुसंधान को वैश्विक स्तर तक ले जाएगा। ‘‘
बंगलुरु स्थित मेटाबोलिक विकारों के लिए केंद्रीय आयुर्वेद अनुसंधान संस्थान के अनुसंधान अधिकारी डॉ. एम एन शुभाश्री ने कहा, ‘‘ इस अध्ययन के मई 2022 में आरभ होने की उम्मीद है इसके अगले दो वर्षों में पूरा हो जाने की आशा की जाती है।
सैंपल का आकार 48 रोगियों से लगभग पांच गुना बढ़कर 240 तक पहुंच गया है। नैदानिक परीक्षण का संचालन तीन स्थानों - कोयंबटूर स्थित एवीपी रिसर्च फाउंडेशन, बंगलुरु स्थित मेटाबोलिक विकारों के लिए केंद्रीय आयुर्वेद अनुसंधान संस्थान तथा मुंबई स्थित राजा रामदेव आनंदीलाला केंद्रीय कैंसर अनुसंधान संस्थान पर किया जाएगा। ‘‘
इससे पूर्व, अमेरिका स्थित राष्ट्रीय स्वास्थ्य संस्थान ने रुमेटॉयड अर्थराइटिस के लिए क्लासिकल आयुर्वेद उपचार की प्रभावशीलता तथा सुरक्षा का स्टैंडर्ड एलोपैथिक उपचार के साथ तुलना करने के लिए सिएटल में वाशिंगटन विश्वविद्यालय में एक नैदानिक परीक्षण का वित्तपोषण किया था।
इस अध्ययन के निष्कर्ष ऐन्नल्स ऑफ रुमैटिक डिजीजेज तथा जर्नल ऑफ क्लिनिकल रुमेटॉलॉजी जैसे प्रतिष्ठित जर्नलों में प्रकाशित किए गए हैं। पश्चिमी देशों में पारंपरिक तथा आधुनिक चिकित्सा को मिला कर बहुआयामी दृष्टिकोण दिन प्रति दिन बढ़ता जा रहा है। (एजेंसी)
यह भी पढ़े► तनाव दूर करने के लिए अर्जेंटीना की संघीय पुलिस योग को अपनाएगी !
Hyderabad- People suffering from arthritis should maintain an active lifestyle as physical exercise reduces inflammation by reducing fat and increasing the production and release of anti-inflammatory molecules, say doctors on World Arthritis Day.
Each year, October 12 is commemorated as World Arthritis Day, and this year, doctors recommend people to take a pledge to enhance awareness about arthritis, its related problems, to stay fit and active, and strive towards reducing the overall arthritis case burden in the country.
Arthritis is an autoimmune condition or a degenerative joint disorder, both causing inflammation in the joints, and these are chronic-cum debilitating problems. At present, there is no specified cure for this ailment, except to live with the problem and manage it from time to time, using steroids. Arthritis can cause severe pain, reduces the quality of life, and decrease people's ability to function.
Doctors warn that more Indians could become victims of arthritis-linked problems due to overweight and obesity. The prevalence of overweight and obesity in India is increasing faster than the world average.
The prevalence of overweight increased from 8.4 percent to 15.5 percent among women between 1998 and 2020, and the prevalence of obesity increased from 2.2 percent to 5.1 percent over the same period. Men are not behind in this problem, and together they are adding to the rising burden of arthritis cases in the country.
"Overweight or obesity along with problems like diabetes, suffering from a traumatic injury to joints, congenital joint deformities, could lead to arthritis problems. While there is a slight difference in osteoarthritis and rheumatoid arthritis, both cause severe damage to human functions. And people who are obese are likely to suffer more than lighter peers after they cross a certain age threshold," said Jagan Mohan Reddy, Consultant Orthopedic Surgeon, SLG Hospitals.
According to K. Saketh, Consultant Orthopedic Surgeon (Sports Surgery & Regenerative Orthopedics), Gleneagles Global Hospital, severe pain in the joints deter arthritis patients from taking up any physical activity due to fear that it could worsen their condition.
"But it is important that individuals suffering from arthritis maintain an active lifestyle. Otherwise, a sedentary lifestyle will further debilitate their ability to do any physical activity, and this could have a severe psychological bearing on the mind. Hence, it is important arthritis patients do not stay immobile and instead motivate themselves to walk or exercise regularly."
Satyanarayana V V, Consultant Orthopedic Surgeon, Aware Gleneagles Global Hospital, pointed out that physical exercise reduces inflammation by reducing fat and increasing the production and release of anti-inflammatory molecules from human muscles.
"Given that inflammation is a primary cause of joint pain in arthritis, exercising will help improve symptoms and will play a crucial role in managing the problem," he said.
Read More► Myth or Fact: Exercise Must Be Avoided After A Heart Attack
London, July 7 (IANS) Arthritis drugs tocilizumab and sarilumab can reduce the risk of death and the need for mechanical ventilation in patients with Covid-19, finds a study.The results, based on analysis of 27 randomised trials in 28 countries involving nearly 11,000 patients, have also prompted the World Health Organisation (WHO) to recommend its use in patients with severe or critical Covid-19 along with corticosteroids.The study, published in the Journal of the American Medical Association (JAMA), showed that administering one of these drugs in addition to corticosteroids, in hospitalised patients, reduces the risk of death by 17 per cent, compared to the use of corticosteroids alone.In patients not on mechanical ventilation, the risk of mechanical ventilation or death is reduced by 21 per cent, compared to the use of corticosteroids alone.These are the first drugs found to be effective against Covid-19 since corticosteroids were recommended by WHO in September 2020.Patients severely or critically ill with Covid-19 often suffer from an overreaction of the immune system, which can be very harmful to the patient's health. Interleukin-6 blocking drugs -- tocilizumab and sarilumab -- act to suppress this overreaction."These drugs offer hope for patients and families who are suffering from the devastating impact of severe and critical Covid-19. But IL-6 receptor blockers remain inaccessible and unaffordable for the majority of the world," WHO Director General Dr Tedros Adhanom Ghebreyesus said in a statement."The inequitable distribution of vaccines means that people in low- and middle-income countries are most susceptible to severe forms of Covid-19. So, the greatest need for these drugs is in countries that currently have the least access. We must urgently change this."To increase access and affordability of these life-saving products, the WHO called on manufacturers to reduce prices and make supplies available to low- and middle-income countries, especially where Covid-19 is surging.--IANSrvt/vd
Dear Patron, Please provide additional information to validate your profile and continue to participate in engagement activities and purchase medicine.